vs
Inspirato Inc（ISPO）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
Inspirato Inc的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.6倍（$55.5M vs $35.5M），Inspirato Inc净利率更高（-8.1% vs -304.2%，领先296.1%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -19.6%），Inspirato Inc自由现金流更多（$-3.0M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -11.4%）
Inspirato Inc是一家高端旅行及酒店订阅服务供应商，主要面向北美高净值人群，提供精选豪华别墅租赁、专属度假村权益、定制化行程规划服务，同时也为企业客户提供高端员工差旅激励解决方案。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
ISPO vs RXRX — 直观对比
营收规模更大
ISPO
是对方的1.6倍
$35.5M
营收增速更快
RXRX
高出701.4%
-19.6%
净利率更高
ISPO
高出296.1%
-304.2%
自由现金流更多
ISPO
多$44.3M
$-47.3M
两年增速更快
RXRX
近两年复合增速
-11.4%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $55.5M | $35.5M |
| 净利润 | $-4.5M | $-108.1M |
| 毛利率 | 31.4% | 59.8% |
| 营业利润率 | -8.0% | -304.8% |
| 净利率 | -8.1% | -304.2% |
| 营收同比 | -19.6% | 681.7% |
| 净利润同比 | -204.4% | 39.6% |
| 每股收益（稀释后） | $-0.36 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ISPORXRX
| Q4 25 | — | $35.5M | ||
| Q3 25 | $55.5M | $5.2M | ||
| Q2 25 | $63.1M | $19.2M | ||
| Q1 25 | $65.9M | $14.7M | ||
| Q4 24 | $63.1M | $4.5M | ||
| Q3 24 | $69.1M | $26.1M | ||
| Q2 24 | $67.4M | $14.4M | ||
| Q1 24 | $80.2M | $13.8M |
净利润ISPORXRX
| Q4 25 | — | $-108.1M | ||
| Q3 25 | $-4.5M | $-162.3M | ||
| Q2 25 | $-5.3M | $-171.9M | ||
| Q1 25 | $1.6M | $-202.5M | ||
| Q4 24 | $-2.3M | $-178.9M | ||
| Q3 24 | $4.3M | $-95.8M | ||
| Q2 24 | $-8.7M | $-97.5M | ||
| Q1 24 | $1.3M | $-91.4M |
毛利率ISPORXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | 31.4% | -183.8% | ||
| Q2 25 | 27.5% | -4.9% | ||
| Q1 25 | 38.8% | -48.0% | ||
| Q4 24 | 34.7% | -181.4% | ||
| Q3 24 | 71.5% | 53.7% | ||
| Q2 24 | 24.0% | 36.2% | ||
| Q1 24 | 39.5% | 19.1% |
营业利润率ISPORXRX
| Q4 25 | — | -304.8% | ||
| Q3 25 | -8.0% | -3327.6% | ||
| Q2 25 | -8.3% | -916.8% | ||
| Q1 25 | 2.5% | -1297.9% | ||
| Q4 24 | -3.2% | -4042.4% | ||
| Q3 24 | 9.8% | -377.1% | ||
| Q2 24 | -22.8% | -697.4% | ||
| Q1 24 | 3.0% | -698.4% |
净利率ISPORXRX
| Q4 25 | — | -304.2% | ||
| Q3 25 | -8.1% | -3135.3% | ||
| Q2 25 | -8.4% | -894.2% | ||
| Q1 25 | 2.5% | -1373.3% | ||
| Q4 24 | -3.6% | -3935.5% | ||
| Q3 24 | 6.3% | -367.5% | ||
| Q2 24 | -12.9% | -676.6% | ||
| Q1 24 | 1.6% | -662.4% |
每股收益（稀释后）ISPORXRX
| Q4 25 | — | $-0.17 | ||
| Q3 25 | $-0.36 | $-0.36 | ||
| Q2 25 | $-0.42 | $-0.41 | ||
| Q1 25 | $0.12 | $-0.50 | ||
| Q4 24 | $0.98 | $-0.56 | ||
| Q3 24 | $0.62 | $-0.34 | ||
| Q2 24 | $-2.33 | $-0.40 | ||
| Q1 24 | $-0.18 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $13.7M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $-134.0M | $1.1B |
| 总资产 | $228.3M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资ISPORXRX
| Q4 25 | — | $743.3M | ||
| Q3 25 | $13.7M | $659.8M | ||
| Q2 25 | $16.7M | $525.1M | ||
| Q1 25 | $16.4M | $500.5M | ||
| Q4 24 | $21.8M | $594.4M | ||
| Q3 24 | $13.5M | $427.6M | ||
| Q2 24 | $18.8M | $474.3M | ||
| Q1 24 | $22.6M | $296.3M |
总债务ISPORXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益ISPORXRX
| Q4 25 | — | $1.1B | ||
| Q3 25 | $-134.0M | $1.0B | ||
| Q2 25 | $-129.7M | $919.1M | ||
| Q1 25 | $-125.2M | $933.9M | ||
| Q4 24 | $-129.9M | $1.0B | ||
| Q3 24 | $-134.6M | $524.6M | ||
| Q2 24 | $-35.2M | $584.4M | ||
| Q1 24 | $-27.5M | $401.2M |
总资产ISPORXRX
| Q4 25 | — | $1.5B | ||
| Q3 25 | $228.3M | $1.4B | ||
| Q2 25 | $252.6M | $1.3B | ||
| Q1 25 | $270.1M | $1.3B | ||
| Q4 24 | $273.9M | $1.4B | ||
| Q3 24 | $273.3M | $726.5M | ||
| Q2 24 | $301.7M | $775.9M | ||
| Q1 24 | $313.0M | $557.8M |
负债/权益比ISPORXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.2M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-3.0M | $-47.3M |
| 自由现金流率自由现金流/营收 | -5.4% | -133.1% |
| 资本支出强度资本支出/营收 | 1.4% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-31.2M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流ISPORXRX
| Q4 25 | — | $-46.1M | ||
| Q3 25 | $-2.2M | $-117.4M | ||
| Q2 25 | $1.1M | $-76.4M | ||
| Q1 25 | $-6.6M | $-132.0M | ||
| Q4 24 | $-15.8M | $-115.4M | ||
| Q3 24 | $-13.7M | $-59.2M | ||
| Q2 24 | $-1.8M | $-82.2M | ||
| Q1 24 | $-7.2M | $-102.3M |
自由现金流ISPORXRX
| Q4 25 | — | $-47.3M | ||
| Q3 25 | $-3.0M | $-117.6M | ||
| Q2 25 | $468.0K | $-79.6M | ||
| Q1 25 | $-7.5M | $-133.8M | ||
| Q4 24 | $-21.2M | $-116.7M | ||
| Q3 24 | $-14.8M | $-63.8M | ||
| Q2 24 | $-3.7M | $-83.4M | ||
| Q1 24 | $-8.5M | $-109.0M |
自由现金流率ISPORXRX
| Q4 25 | — | -133.1% | ||
| Q3 25 | -5.4% | -2272.5% | ||
| Q2 25 | 0.7% | -413.9% | ||
| Q1 25 | -11.4% | -907.4% | ||
| Q4 24 | -33.7% | -2567.7% | ||
| Q3 24 | -21.5% | -244.6% | ||
| Q2 24 | -5.5% | -578.5% | ||
| Q1 24 | -10.6% | -789.9% |
资本支出强度ISPORXRX
| Q4 25 | — | 3.5% | ||
| Q3 25 | 1.4% | 4.7% | ||
| Q2 25 | 1.0% | 16.4% | ||
| Q1 25 | 1.3% | 12.4% | ||
| Q4 24 | 8.7% | 28.6% | ||
| Q3 24 | 1.6% | 17.5% | ||
| Q2 24 | 2.8% | 8.2% | ||
| Q1 24 | 1.6% | 48.2% |
现金转化率ISPORXRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -4.09× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -3.16× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -5.70× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ISPO
| Residence And Hotel Travel | $25.9M | 47% |
| Subscription | $19.4M | 35% |
| Experiences And Bespoke Travel | $8.0M | 14% |
| Rewards And Other Revenue | $2.3M | 4% |
RXRX
暂无分部数据
